Seven-figure funding round for diabetes app MySugr



Berlin investor XLHealth today announced a seven-figure investment in Austria and US-based startup MySugr. Founded in 2011, the startup produces apps to manage the treatment of diabetes.

Via its two apps, the MySugr Companion and MySugr Junior Digital, the startup aims to bring “more fun” and enjoyment into the treatment of diabetes. In an interview with VentureVillage late last year, the MySugr founders told us that “too often negative motivation and scare tactics are used when treating diabetes, which leads to sufferers having a negative view of the illness.” The team believes that many diabetics are missing the “stamina, positive feedback and motivation” to improve the treatment process – which they hope their apps can change.

According to the company, MySugr has now attracted close to 100,000 users. Previous investors in the startup include business angel Johann Hansmann and Austria Wirtschaftsservice.

Launched in 2013, XLHealth is an investor and incubator specialising in e-health startups. XLHealth announced its first investment one month ago – together with publishing group Spiegel, it invested a million-figure amount in NeuroNation.

For related posts, check out